期刊文献+

超声造影剂联合超声介导耐药基因反义寡脱氧核苷酸转染肝癌细胞逆转多药耐药效应的研究 被引量:1

Research in QGY/CDDP hepatoma lines multi-drug resistance reversed by ultrasound contrast agent joint ultrasound mediating ASODN of drug resistance gene transfection
原文传递
导出
摘要 目的探讨超声造影剂联合超声介导mdr1、mrp基因反义寡脱氧核苷酸(ASODN)转染QGY耐药肝癌细胞对多药耐药(MDR)的逆转。方法分别将mdr1、mrp-ASODN+超声造影剂+超声辐照转染QGY/CDDP肝癌细胞,检测转染后细胞贴壁率、药物敏感性、耐药基因mRNA表达和相应耐药蛋白表达变化。结果mdr1—ASODN转染后,细胞贴壁率和耐药基因mRNA表达变化大(P〈0.05),细胞药物敏感性和耐药蛋白P-gp、MRP表达变化小(P〉0.05)。实验组(2组)作用更大(P〈0.05)。mrp—As0DN转染后,细胞贴壁率、药物敏感性、耐药基因的mRNA表达和耐药蛋白P-gp、MRP表达均变化明显(P〈().05),实验组(2组)作用更大(P〈0.05)。结论mdrl、mrp—ASODN+超声造影剂+超声辐照能够低毒部分逆转肝癌细胞MDR,是潜在肿瘤基因治疗方法。 Objective To discuss the effect of QGY/CDDP hepatoma lines multi-drug resistance (MDR) reversed by gene transfection of mdrl, mrp-ASODN + ultrasound contrast agent + ultrasound. Methods The QGY/CDDP cells were transfected by mdrl, mrp-ASODN + ultrasound contrast agent + ultrasound irradiation respectively and detected of the various indicators:cell adhesion rate,cell sensitivity to cell drug-resistance, the mRNA expression of mdrl and mrp gene, the expression of P-gp and MRP protein. Results After mdrl-ASODN transfection, the drug sensitivity and expression of P-gp, MRP protein of QGY/CDDP cells were smaller changes( P 〉0.05) ,and the rate of cells adherent and expression of resistance gene mRNA were obvious changes (P 〈 0. 05). After mrp-ASODN transfection, the cells adherent rate, the drug sensitivity, the expression of resistance gene mRNA and P-gp, MRP protein were obvious changes respectively( P 〈0.05 ), the experiment group(group 2') had bigger effects( P 〈0.05 ). Conclusions mdrl, mrp-ASODN + ultrasound contrast agent + ultrasound irradiation could safely partly reverse MDR of hepatoma cells,which is a potential new approach for gene therapy.
出处 《中华超声影像学杂志》 CSCD 2008年第3期258-261,共4页 Chinese Journal of Ultrasonography
基金 国家自然科学基金资助项目(30070230和30570523)
关键词 超声检查 造影剂 肝细胞 基因转移技术 Ultrasonography Contrast media Carcinoma,hepatocellular Gene transfer techniques
  • 相关文献

参考文献2

二级参考文献12

  • 1Zaffaroni N,Lualdi S,Villa R,et al.Inhibition of telomerase activity by a distamycin derivative:effects on cell proliferation and induction of apoptosis in human cancer cells.Eur J Cancer,2002,38:1792-1801.
  • 2He L,Liu GQ.Interaction of multidrug resistance reversal agents with Pglycoprotein ATPase activity on blood-brain barrier.Acta Pharmacol Sin,2002,23:423-429.
  • 3Fojo T,Bates S.Strategies for reversing drug resistance.Oncogene,2003,22:7512-7523.
  • 4Bodo A,Bakos E,Szeri F,et al.The role of multidrug transporters in drug availability,metabolism and toxicity.Toxicol Lett,2003,140-141:133-143.
  • 5Pan L,Tong Y,Jin Y,et al.Reversing drug resistance in the ovarian carcinoma cell line SKOV3/mdrl in vitro by antisense oligodeoxynucleotides.Chin Med J (Engl),2001,114:929-932.
  • 6Itoh M,Noutomi T,Chiba H,et al.BcI-xL antisense treatment sensitizes Bcl-xL-overexpressing squamous cell carcinoma cells to carboplatin.Oral Oncol,2002,38:752-756.
  • 7Masanek U,Stammler G,Volm M.Modulation of multidrug resistance in human ovarian cancer cell lines by inhibition of P-glycoprotein 170and PKC isoenzymes with antisense oligonucleotides.J Exp Ther Oncol,2002,2:37-41.
  • 8Tsang WP,Chau SP,Fung KP,et al.Modulation of multidrug resistance-associated protein 1 (MRP1) by p53 mutant in Saos-2 cells.Cancer Chemother Pharmacol,2003,51:161-166.
  • 9van de Donk NW,Kamphuis MM,van Dijk M,et al.Chemosensitization of myeloma plasma cells by an antisense-mediated downregulation of Bcl-2 protein.Leukemia,2003,17:211-219.
  • 10Stuart DD,Kao GY,Allen TM.A novel,long-circulating,and functional liposomal formulation of antisense oligodeoxynucleotides targeted against MDR1.Cancer Gene Ther,2000,7:466-475.

共引文献48

同被引文献3

  • 1Giannelli G,Antonaci S.Novel concepts in hepatocellular carcinoma:from molecular research to clinical practice.J Clin Gastroenterol,2006,40:842-846.
  • 2Shi M,Guo RP,Lin XJ,et al.Partial hepatectomy with wide versus narrow resection margin for solitary hepatocellular carcinoma:a prospective randomized trial.Ann Surg,2007,245:36-43.
  • 3Ramos E,Llado L,Serrano T,et al.Utility of cell-cycle modulators to predict vascular invasion and recurrence after surgical treatment of hepatocellular carcinoma.Transplantation,2006,82:753-758.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部